Cambios conductuales y hemoquímicos observados en fenilcetonúricos despues de suplementación con ácidos grasos de la serie w3
Texto completo:
PDFResumen
Palabras clave
Referencias
Nelson W. Tratado de Pediatría. Edición Revolucionaria. La Habana: 1988.
Schaffer AJ. Enfermedades del recién nacido. Editorial Científico Técnica. Cuarta Edición. La Habana: 1981.
Cooke RE. Bases biológicas de la práctica pediátrica. Salvat Editores. Barcelona: 1970.
Robbins SL. Patología estructural y funcional. Nueva Editora Interamericana. Ciudad México: 1975. pp 548-49.
Gutiérrez E, Barrios B, Mar J. Estudio de portadores de Fenilcetonuria y otras hiperfenil-alaninemias por prueba de tolerancia a la fenilalanina. Rev Cubana Ped 1993;65:88-9.
Neuringer M, Connor WE, Lin DS, Barstd L, Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1983;41:4021-5.
Food, Nutrition and Agriculture. Recomendaciones de expertos sobre las grasas y aceites en la nutrición humana - 11: Edible Fats and Oils. FAO/FPND. Geneva: 1994. 72 páginas.
Cheng HH, Wen YY, Chen C. Serum fatty acid composition in primary school children is associated with serum cholesterol levels and dietary fat intake. Eur J Clin Nutr 2003;57:1613-20.
Ballesteros MN, Cabrera RM, Saucedo L, Fernández ML. Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico. Am J Clin Nutr 2004; 80:855-61.
Lehninger AL. Bioquímica. Las bases moleculares de la estructura y función celular. Segunda Edición. Editorial Pueblo y Revolución. La Habana: 1981.
Clarke SD. El genoma humano y la nutrición. En: Conocimientos Actuales sobre Nutrición. Publicación científica 592. Octava Edición. OMS Organización Mundial de la Salud. Washington: 2003. pp 117-27.
Valenzuela BA, Nieto MS. Ácido docosahexaenoico (DHA) en el desarrollo fetal y en la nutrición materno-infantil. Rev Méd Chile 2001; 129:1203-11.
Alfonso Valenzuela B. El salmón: Un banquete de salud. Rev Chil Nutr 2005;32:8-17.
Solórzano del Río HE. Funciones de la Fenilalanina. En: Terapia bioquímica nutricional. UDG Universidad de Guadalajara. Guadalajara: 1998.
Berdonces JL. Las proteínas. Revista ROL de Enfermería 2001;24:171-4.
Scriver CR, Beaudet AL, Sly WS. The Metabolic Basis of Inherited Diseases. Octava Edición. McGraw-Hill Book Company. New York: 2000.
Wilcox WR, Cederbaum SD. Aminoacid metabolism. En: Principles and Practices of Medical Genetics (Editores: Emery, Rimoin). Cuarta Edición. Churchill Livingstone. London: 2002. pp 2405-40.
Díaz-Argüelles Ramírez-Corría V, Pupo PL, González MA. Desbalance energético proteico en lactantes. Rev Cubana Pediatr 2004;2:18-23.
Infante JP, Huszagh VA. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. Mol Genet Metab 2001;72:185-98.
Watson D. A simple method for the determination of serum cholesterol. Clin Chim Acta 1960;5:637-39.
Carlson LA. Determination of serum triglycerides. J Atheroesclerosis Res 1963;3:333-5.
Politi P, Cena H, Comelli M, Marrone G, Allegri C, Emanuele E, Ucelli di Nemia S. Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: An open label study. Arch Med Res 2008;39:682-5.
Pierre Weil’s Non-verbal intelligence test. En: AERA American Educational Research Association, APA American Psychology Association & NCME National Council on Measurement in Education. Standards for educational and psychological testing. American Educational Research Association. New York: 1999.
Marcos Plasencia L. Manual de Soporte Alimentario Nutrimental y Metabólico de los fenilcetonúricos en Cuba. La Habana: 2006. ISBN 259-212-205-9. Disponible en: http://www.bvs.sld.cu/libros/manual_soportealimentarionutricional_metabolico_fenilcetonuria/indice_p.htm. Fecha de última visita: 23 de Febrero del 2009.
Canalejo Martínez H, Santana Porbén S. Manual de procedimientos bioestadísticos. Editorial Ciencias Médicas. La Habana: 1990.
Siegel S, Castellan Jr J. Estadística no paramétrica. Editorial Trillas. Ciudad México: 1998.
Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 2007;61:551-3.
Uauy R, Hoffman D, Peirano P, Birch D, Birch E. Essential fatty acids in visual and brain development. Lipids 2001;36:885-95.
Uauy R, Valenzuela A. Marine oils: Health benefits of n-3 fatty acids. Nutrition 2000;16:680-4.
Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid. Pharmacol Res 1999;40: 211-25.
Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999; 70:961-70.
Ordóñez JA, Cambero MI, Arrigo M, de la Hoz L. Importancia de los ácidos grasos poliinsaturados en la salud humana y enriquecimiento de la carne y productos cárnicos en ácidos grasos de la familia n-3 (Segunda parte). Alimentación, Nutrición y Salud 2001; 10:31-40.
Sanhueza J, Nieto S, Valenzuela A. Acido docosahexaenoico (DHA), desarrollo cerebral, memoria y aprendizaje: la importancia de la suplementación perinatal. Rev Chil Nutr 2004;31:84-92.
Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT. Maternal docosahexaenoic acid supplementation and fetal accretion. Brit J Nutr 2003;90:135-45.
Connoer WE, Lowensohn R, Hatcher L. Increased docosahexaenoic acid levels in human newborn by administration of sardines and fish oil during pregnancy. Lipids 1996;31(Suppl):S183-S187.
Crawford M. Placental delivery of arachidonic and docosahexaenoic acids: implications for the lipid nutrition of preterm infants. Am J Clin Nutr 2000; 71:275-84.
Valenzuela A, Nieto S. Ácidos grasos omega-6 y omega-3 en la nutrición perinatal: Su importancia en el desarrollo del sistema nervioso y visual. Rev Chil Ped 2003;74:149-57.
Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin, M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. The Lancet 1998;352: 688-91.
Agostoni C, Trojan S, Bellú R, Riva E, Brunezze M, Giovannini M. Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow-up study. Arch Dis Child 1997;76:421-4.
Stordy J. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. Am J Clin Nutr 2000;71:323-6.
Richardson AJ, Puri BK. The potential role of fatty acids in attention deficit hyperactivity disorder. Prost Leuk Essent Fatty Acids 2000;63:79-87.
Burgess JR, Stevens L, Zhang W, Peck L. Long-chain polyunsaturated fatty acids in children with attention deficit hyperactivity disorder. Am J Clin Nutr 2000;71:27-30.
Hibbeln JR. Essential fatty acid predicts biomarkers of aggression and depression. PUFA Newslett 1997;1:2.
Hibbeln JR, Salem N. Dietary polyunsaturated fatty acid and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995;62:1-9.
Bistrian BR. Clinical aspects of essential fatty acid metabolism. JPEN J Parenter Enter Nutr 2003;27:168-75.
Clandinin MT. Brain development and assessing the supply of polyunsaturated fatty acid. Lipids 1999;34:131-7.
Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M; et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006;67: 1954-67.
Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 2005;65:1051-9.
Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis 2007;6:21.
Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsych Biol Psych 2002;26:233-9.
Agostoni C, Riva E, Biasucci G, Luotti D, Bruzzese MG, Marangoni F, Giovannini M. The effects of n-3 and n-6 polyunsaturated fatty acids on plasma lipids and fatty acids of treated phenylketonuric children. Prostaglandins Leukot Essent Fatty Acids 1995;53:401-4.
Okuyama H, Fujii J, Ikamoto A. N-6/N-3 ratio of dietary fatty acids rather than hypercholesterolemia as the mayor risk factor for atherosclerosis and coronary heart disease. J Health Sci 2000;46:157.
Beblo S, Reinhardt H, Demmelmair H. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr 2007;150: 479-84.
Agostoni C, Scaglioni S, Bonvissuto M, Bruzzese MG, GiovanniniM, Riva, E. Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia. Prostaglandins Leukot Essent Fatty Acids 2001;64:111-5.
GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. The Lancet 1999;354:447-55.
Agostoni C, Riva E, Galli C, Marangoni F, Luotti D, Giovannini M. Plasma arachidonic acid and serum thromboxane B2 concentrations in phenylketonuric children are correlated with dietary compliance. Z Ernahrungswiss 1998; 37(Suppl 1):122-4.
Putnam J, Carlson S, DeVoe P, Barness L. The effect of variations in dietary fatty acids on the fatty acid composition of erythrocyte phosphatidylcholine and phosphatidylethanolamine in human infants. Am J Clin Nutr 1982;36:106-14.
Makrides M, Neumann M, Byard R, Simmer K, Gibson R: Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994;60:189-94.
Lapillone A, Brossard N, Claris O, Reygrobellet B, Salle Bl: Erythrocyte fatty acid composition in term infants fed human milk or a formula enriched with a low eicosapentaenoic acid fish oil for 4 months. Eur J Pediatr 2000;159: 49-53.
Meléndez Martínez AJ, Vicario IM, Heredia FJ. Carotenoid pigments: Structural and physicochemical considerations. Arch Latinoam Nutr 2007;57:109-17.
Porrata Maury C, Hernández Triana M, Argüelles Vázquez JM. Recomendaciones nutricionales y guías de alimentación para la población cubana. Editorial Pueblo y Educación. La Habana: 1996.
Aráuz AG, Jiménez JG. Pauta para el tratamiento dietético y farmacológico de las dislipoproteinemias. INCIENSA/INCAP/OPS. Tres Ríos. Costa Rica: 1992.
Enlaces refback
- No hay ningún enlace refback.
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.